Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ferre

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Schizophrenia Research|May 3, 1997
Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET studyV Molina Rodríguez, R Montz Andrée, M J Pérez Castejón, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2004
Profiles of brain magnetic activity during a memory task in patients with Alzheimer's disease and in non-demented elderly subjects, with or without depressionF Maestú, A Fernandez, P G Simos, et al.
AIDS Research and Human Retroviruses|February 1, 1992
Quantitation of HIV viral burden by PCR in HIV seropositive Navy personnel representing Walter Reed stages 1 to 6F Ferre, A Marchese, P C Duffy, et al.
The Journal of Infectious Diseases|June 1, 1994
Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cellsR J Trauger, F Ferre, A E Daigle, et al.
Revista Clinica Espanola|April 29, 1998
[Prevalence of psychiatric disturbances and psychopathologic status in patients with systemic lupus erythematosus]G Rubio Valladolid, A Gil Aguado, A Balsa Criado, et al.
Journal of Clinical Immunology|September 1, 1996
Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIV-1 immunogen and antiviral drug therapyR B Moss, F Ferre, A Levine, et al.
Immunology|April 1, 1993
Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burdenR J Trauger, W K Giermakowska, F Ferre, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|February 21, 2023
Impact of the COVID-19 pandemic on the mental health of the general population and health care workersE Bouza, C Arango, C Moreno, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1997
Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infectionR B Moss, R J Trauger, W K Giermakowska, et al.
Clinical and Experimental Immunology|July 9, 2002
Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccineD L Shawler, R M Bartholomew, M A Garrett, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Schizophrenia Research|May 3, 1997
Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET studyV Molina Rodríguez, R Montz Andrée, M J Pérez Castejón, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2004
Profiles of brain magnetic activity during a memory task in patients with Alzheimer's disease and in non-demented elderly subjects, with or without depressionF Maestú, A Fernandez, P G Simos, et al.
AIDS Research and Human Retroviruses|February 1, 1992
Quantitation of HIV viral burden by PCR in HIV seropositive Navy personnel representing Walter Reed stages 1 to 6F Ferre, A Marchese, P C Duffy, et al.
The Journal of Infectious Diseases|June 1, 1994
Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cellsR J Trauger, F Ferre, A E Daigle, et al.
Revista Clinica Espanola|April 29, 1998
[Prevalence of psychiatric disturbances and psychopathologic status in patients with systemic lupus erythematosus]G Rubio Valladolid, A Gil Aguado, A Balsa Criado, et al.
Journal of Clinical Immunology|September 1, 1996
Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIV-1 immunogen and antiviral drug therapyR B Moss, F Ferre, A Levine, et al.
Immunology|April 1, 1993
Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burdenR J Trauger, W K Giermakowska, F Ferre, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|February 21, 2023
Impact of the COVID-19 pandemic on the mental health of the general population and health care workersE Bouza, C Arango, C Moreno, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1997
Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infectionR B Moss, R J Trauger, W K Giermakowska, et al.
Clinical and Experimental Immunology|July 9, 2002
Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccineD L Shawler, R M Bartholomew, M A Garrett, et al.
Pageof 8